Pancreatic cancer cells can “starve”, thanks to a combination of a new type of cancer drug and a keto diet, an early study suggests.
Researchers said that their new study points to a “vulnerability” that could potentially lead to a new treatment for pancreatic cancer, which has notoriously poor outcomes.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
